Quantum BioPharma (NASDAQ: $QNTM)

His Honourable Senator Ted Kaufman Comments on Spoofing. https://lnkd.in/gZ9j6Tau #Spoofing #Banking #Marketplace #Nasdaq #NYSE #CSE #TSX

Freedman Normand Friedland LLP has filed a complaint in the United States District Court for the Southern District of New York on behalf of Quantum BioPharma (NASDAQ: $QNTM) alleging that CIBC World Markets, RBC Dominion Securities, and others engaged in market manipulation schemes that violated Section 10(b) and Rule 10b-5(a) and (c) and Section 9(a) of the Securities Exchange Act of 1934.

Quantum Biopharma (NASDAQ $QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing https://lnkd.in/gZ9j6Tau

Quantum BioPharma sues over alleged stock spoofing news article by The Globe and Mail https://lnkd.in/gJ-__PvM #QuantumBioPharma #StockSpoofing #MarketManipulation #Lawsuit #BiotechNews #QuantumLawsuit #FinancialJustice #StockMarket #SpoofingAllegations #InvestorProtection #MarketIntegrity #Biotech #FinancialMarkets #PharmaNews

Our partners at Celly Nutrition Corp. and Kevin Harrington have just been featured on Forbes. 👏🏻 https://lnkd.in/gjvs3VQs Get it now at www.unbuzzd.com so you can drink responsibly and refreshingly. #hangover #getunbuzzd #beverage #usa #markets #business #nasdaq

Quantum BioPharma (Nasdaq: QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing https://lnkd.in/gEnAqf4P

Quantum BioPharma is making waves in the biotech space, and we're excited to spotlight one of our standout innovations—unbuzzd. This revolutionary beverage is set to transform how we recover after a night out, keeping you clear-headed, energized, and refreshed with every sip. Check out this feature article: 🔗 Meet unbuzzd: A Drink Slated to Kill the Hangover https://lnkd.in/gh4DYEfe Let’s toast to smarter drinking and bright mornings. #Beverages #Drinks #Hangover #Beverage #Business #Nasdaq #Biotech #unbuzzd #getunbuzzd #cleareyedcitrus #refreshrejuvinaterecover #drinkresponsiblydrinkrefreshingly #ownwhatsnowandnext #QuantumBioPharma

Stack3d Article about unbuzzd from our partners at Celly Nutrition Corp. Their convenient, grab-and-go powdered sticks are now available for purchase on Amazon! (www.unbuzzd.com) Whether you're recovering from a night out or looking to boost your day with clarity and focus, unbuzzd has you covered. https://lnkd.in/gdtMwjuQ #unbuzzd #getunbuzzd #drinkresponsiblydrinkrefreshingly #ownwhatsnowandnext #cleareyedcitrus #refreshrejuvinaterecover #hangover #beverage #alcohol #USA #Amazon

At Quantum BioPharma, we recognize the intricate nature of Multiple Sclerosis (MS) and other neurodegenerative diseases. These conditions involve numerous factors that drive the neurodegenerative process, and recent insights suggest MS may not be solely an autoimmune disorder, but also have a significant neurodegenerative component. Our lead therapeutic candidate Lucid-MS, is designed to address this complexity through a process known as remyelination. The drug has shown promising results in an earlier Phase 1 study. We are looking forward to continuing the development of Lucid-MS for potential treatment of progressive MS, an indication where there is an unmet need for novel, non-immunomodulatory treatments. The way Remyelination works in theory is that it facilitates the stimulation of oligodendrocyte precursor cells to differentiate into oligodendrocytes, thereby generating new myelin sheaths on demyelinated axons within the central nervous system (CNS). This process is naturally regulated within the body and is typically highly efficient in a healthy CNS. At Quantum BioPharma, we are committed to advancing the understanding and treatment of neurodegenerative diseases by exploring innovative approaches like Lucid-MS to promote CNS repair. #Biotechnology #Lifescience #Health #Brainhealth #MS #Multiplesclerosis #Neurodegenerative #Diseases #LucidMSBreakthrough #MSResearchAdvances #MyelinRepairRevolution #NonImmunomodulatory #MSHope #SafeAndWellTolerated #ProgressiveMS #InnovatingForMS #NeurologicalBreakthrough

Another Episode of Meet the Team Dr. Andrzej Chruscinski MD, PhD Dr. Chruscinski will be leading our clinical programs and help lead our clinical trials as Associate Vice-President, Clinical Affairs. Dr. Chruscinski received his MD, PhD from Stanford University, followed by residency in internal medicine at Stanford, fellowship in cardiology at Stanford and Toronto General, and recently led two major clinical trials investigating tolerance in transplantation and new biomarkers discovery. He is a board certified cardiologist and carries active medical license in Michigan. #Biotech #MS #Multiplesclerosis #Neurodegenerative #Brainhealth #Remyelination